Combining magnetic nanoparticle with biotinylated nanobodies for rapid and sensitive detection of influenza H3N2

Nanoscale Research Letters

Volumn 9, Issue 1, 2014, Pages

  Zhu, Min ^a,b   Hu, Yonghong ^c   Li, Guirong ^b   Ou, Weijun ^b   Mao, Panyong ^d   Xin, Shaojie ^d   Wan, Yakun ^a,b  

^a SOUTHEAST UNIVERSITY   (China)

^b Jiangsu Nanobody Engineering and Research Center   (China)

^c NANJING TECH UNIVERSITY   (China)

^d BEIJING 302 HOSPITAL   (China)

Author keywords

Biotinylation; Influenza A grade 2 (H3N2); Magnetic nanoparticles; Nanobody

Indexed keywords

DIAGNOSTIC PRODUCTS; ESCHERICHIA COLI; NANOPARTICLES; PROTEINS;

BIOTINYLATIONS; HEAVY-CHAIN ANTIBODIES; HIGH SENSITIVE DETECTION; HORSERADISH PEROXIDASE; INFLUENZA A; MAGNETIC NANO-PARTICLES; NANOBODY; OPTIMIZED CONDITIONS;

NANOMAGNETICS;

ARMORACIA RUSTICANA; ESCHERICHIA COLI;

EID: 84928413197     PISSN: 19317573     EISSN: 1556276X     Source Type: Journal    
DOI: 10.1186/1556-276X-9-528     Document Type: Article

References (24)

1. Taubenberger JK, Morens DM: Influenza: the once and future pandemic.Public Health Rep 2010,125(Suppl 3):16–26.
2. Nidzworski D, Pranszke P, Grudniewska M, Krol E, Gromadzka B: Universal biosensor for detection of influenza virus.Biosens Bioelectron 2014, 59C:239–242.
3. Thangavel RR, Bouvier NM: Animal models for influenza virus pathogenesis, transmission, and immunology.J Immunol Methods 2014, 410:60–79.
4. Deng YM, Caldwell N, Barr IG: Rapid detection and subtyping of human influenza A viruses and reassortants by pyrosequencing.PLoS One 2011, 6:e23400.
5. Wei SH, Yang JR, Wu HS, Chang MC, Lin JS, Lin CY, Liu YL, Lo YC, Yang CH, Chuang JH, Lin MC, Chung WC, Liao CH, Lee MS, Huang WT, Chen PJ, Liu MT, Chang FY: Human infection with avian influenza A H6N1 virus: an epidemiological analysis.Lancet Respir Med 2013, 1:771–778.
6. Claas EC: Pandemic influenza is a zoonosis, as it requires introduction of avian-like gene segments in the human population.Vet Microbiol 2000, 74:133–139.
7. Juno J, Fowke KR, Keynan Y: Immunogenetic factors associated with severe respiratory illness caused by zoonotic H1N1 and H5N1 influenza viruses.Clin Dev Immunol 2012, 2012:797180.
8. Centers for Disease C, Prevention: Prevention and control of seasonal influenza with vaccines. Recommendations of the Advisory Committee on Immunization Practices--United States, 2013–2014.MMWR Recomm Rep 2013, 62:1–43.
9. Krejcova L, Dospivova D, Ryvolova M, Kopel P, Hynek D, Krizkova S, Hubalek J, Adam V, Kizek R: Paramagnetic particles coupled with an automated flow injection analysis as a tool for influenza viral protein detection.Electrophoresis 2012, 33:3195–3204.
10. Storch GA: Diagnostic virology.Clin Infect Dis 2000, 31:739–751.
11. He Q, Velumani S, Du Q, Lim CW, Ng FK, Donis R, Kwang J: Detection of H5 avian influenza viruses by antigen-capture enzyme-linked immunosorbent assay using H5-specific monoclonal antibody.Clin Vaccine Immunol 2007, 14:617–623.
12. Fouchier RA, Bestebroer TM, Herfst S, Van Der Kemp L, Rimmelzwaan GF, Osterhaus AD: Detection of influenza A viruses from different species by PCR amplification of conserved sequences in the matrix gene.J Clin Microbiol 2000, 38:4096–4101.
13. Muyldermans S, Baral TN, Retamozzo VC, De Baetselier P, De Genst E, Kinne J, Leonhardt H, Magez S, Nguyen VK, Revets H, Rothbauer U, Stijlemans B, Tillib S, Wernery U, Wyns L, Hassanzadeh-Ghassabeh G, Saerens D: Camelid immunoglobulins and nanobody technology.Vet Immunol Immunopathol 2009, 128:178–183.
14. de Marco A: Biotechnological applications of recombinant single-domain antibody fragments.Microb Cell Fact 2011, 10:44.
15. Hassanzadeh-Ghassabeh G, Devoogdt N, De Pauw P, Vincke C, Muyldermans S: Nanobodies and their potential applications.Nanomedicine 2013, 8:1013–1026.
16. Ma L, Sun Y, Kang X, Wan Y: Development of nanobody-based flow injection chemiluminescence immunoassay for sensitive detection of human prealbumin.Biosens Bioelectron 2014, 61C:165–171.
17. Franco EJ, Sonneson GJ, DeLegge TJ, Hofstetter H, Horn JR, Hofstetter O: Production and characterization of a genetically engineered anti-caffeine camelid antibody and its use in immunoaffinity chromatography.J Chromatogr B Analyt Technol Biomed Life Sci 2010, 878:177–186.
18. Vincke C, Gutierrez C, Wernery U, Devoogdt N, Hassanzadeh-Ghassabeh G, Muyldermans S: Generation of single domain antibody fragments derived from camelids and generation of manifold constructs.Methods Mol Biol 2012, 907:145–176.
19. Cloutier SM, Couty S, Terskikh A, Marguerat L, Crivelli V, Pugnieres M, Mani JC, Leisinger HJ, Mach JP, Deperthes D: Streptabody, a high avidity molecule made by tetramerization of in vivo biotinylated, phage display-selected scFv fragments on streptavidin.Mol Immunol 2000, 37:1067–1077.
20. Conrath KE, Lauwereys M, Galleni M, Matagne A, Frere JM, Kinne J, Wyns L, Muyldermans S: Beta-lactamase inhibitors derived from single-domain antibody fragments elicited in the camelidae.Antimicrob Agents Chemother 2001, 45:2807–2812.
21. Mu B, Huang X, Bu P, Zhuang J, Cheng Z, Feng J, Yang D, Dong C, Zhang J, Yan X: Influenza virus detection with pentabody-activated nanoparticles.J Virol Methods 2010, 169:282–289.
22. Li H, Sun Y, Elseviers J, Muyldermans S, Liu S, Wan Y: A nanobody-based electrochemiluminescent immunosensor for sensitive detection of human procalcitonin.Analyst 2014, 139:3718–3721.
23. Zhang Y, Zhou D: Magnetic particle-based ultrasensitive biosensors for diagnostics.Expert Rev Mol Diagn 2012, 12:565–571.
24. Fanjul-Bolado P, Gonzalez-Garcia MB, Costa-Garcia A: Amperometric detection in TMB/HRP-based assays.Anal Bioanal Chem 2005, 382:297–302.